Intrapleural streptokinase for pleural infection a step forward in managing pleural effusions?
胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步吗？
Objective: To study the efficacy of KLT by intrapleural injection in treating malignant pleural effusion.
目的：探讨康莱特(KLT)腔内注射对恶性胸腔积液治疗的价值。
Objective To observe the therapeutic effect of intrapleural urokinase in treatment of tuberculosis pleurisy.
目的观察胸腔内注入尿激酶减少结核性渗出性胸膜炎胸膜粘连的效果。
Objective: To observe the effects of intrapleural urokinase in the treatment of the tuberculous pleural effusion.
前言：目的：观察胸膜腔内注入尿激酶治疗结核性胸膜炎的效果。
Objective To observe the therapeutic effects of intrapleural injection of Lentinan (LNT) in the treatment of malignant effusion.
目的探索香菇多糖(LNT)腔内注射对恶性胸腔积液的治疗价值。
Objective To observe the effects of intrapleural urokinase in the treatment of pleural thickening and loculated pleural effusion.
目的观察胸腔内注射尿激酶治疗结核性胸膜炎的效果。
Conclusion Intrapleural injections of recombinant IL-2 are simple and effective for treatment of patients with refractory pneumothorax.
结论胸腔内注射白细胞介素- 2治疗难治性气胸是一种简单、有效的方法。
Objective To explore the role of micro-tube drainage and intrapleural urokinase for patients with tuberculous loculated encysted pleurisy.
目的探讨微管引流并注入尿激酶治疗结核性多房包裹性胸腔积液的疗效。
Conclusion Intrapleural urokinase not only reduces pleural adhesion, loculation and thickening of the pleura, but also improves lung function.
结论胸腔内注射尿激酶能减少胸腔分隔、多房的形成。减少胸膜肥厚，改善肺功能。
AIM: to observe the clinical efficacy of Nocardia rubra cell wall skeleton (n CWS) in the treatment of malignant pleural effusion by intrapleural injection.
目的：观察红色诺卡菌细胞壁骨架(NCWS)胸腔内注射治疗恶性胸腔积液的临床疗效。
Objective:To observe clinic curative effect of combined cis-platinum intrapleural infusion with Li Fei decoction in treatment for malignant pleuritic fluid.
目的：观察顺铂胸腔灌注合中药利肺汤对癌性胸水的临床疗效。
Objective: To study the efficacy and safety of intrapleural injection of lobaplatin combined with endostar in treatment of lung cancer with malignant pleural effusion.
目的：研究洛铂联合重组人血管内皮抑素（恩度）治疗肺癌恶性胸腔积液的有效性和安全性。
Methods: To observe the responses, adverse reactions and peripheral blood immune indexes in 27 cases with malignant pleural effusion after the intrapleural injection of KLT.
方法：观察27例恶性胸腔积液患者腔内注射KLT后的疗效、不良反应及外周血免疫指标变化。
The intrapleural instillation of cryoprecipitate could significantly lower the recurrence rate of ipsilateral pneumothorax and could not lead to restrictive pulmonary dysfunction.
结论：胸膜腔内注入冷沉淀能有效地降低同侧气胸的复发率，且不会导致限制性肺功能障碍。
Conclusion the intrapleural urokinase injection can effectively dissolves the fiber partition in loculated effusions by tuberculous pleurisy and prevent pleural thickening and adhesion.
结论胸膜腔内注入尿激酶，能有效溶解结核性包裹性胸腔积液中的纤维分隔，明显降低胸膜肥厚的程度和粘连发生的机会。
Conclusion the results show that intrapleural injection of Cisplatin combined with NP regimen adjuvant chemotherapy can be regarded as an effective method on malignant pleural effusions.
结论顺铂胸腔注入联合NP方案化疗治疗肺癌恶性胸腔积液可以提高疗效并且对身体损伤较小。
Conclusion the results show that intrapleural injection of Cisplatin combined with NP regimen adjuvant chemotherapy can be regarded as an effective method on malignant pleural effusions.
结论顺铂胸腔注入联合NP方案化疗治疗肺癌恶性胸腔积液可以提高疗效并且对身体损伤较小。
应用推荐